Management of ileal stenosis in patients with Crohn's disease;Prise en charge des sténoses iléales de maladie de Crohn

Gastroenterologie Clinique et Biologique

Volumn 33, Issue 10-11 SUPPL., 2009, Pages

  Coelho, J ^a,b   Soyer, P ^a,b   Pautrat, K ^a   Boudiaf, M ^a   Vahedi, K ^a   Reignier, S ^a,b   Valleur, P ^a,b   Marteau, P ^a,b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DRUG COMBINATION; HOSPITALIZATION; HUMAN; ILEUM DISEASE; INTESTINE OBSTRUCTION; LAPAROSCOPY; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; ILEAL DISEASES; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL OBSTRUCTION; LAPAROSCOPY; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77951625036     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2009.07.024     Document Type: Article

References (35)

1. Cosnes J., Cattan S., Blain A., Beaugerie L., Carbonnel F., Parc R., et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002, 8:244-250.
2. Louis E., Collard A., Oger A.F., Degroote E., Aboul Nasr El Yafi F.A., Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001, 49:777-782.
3. Travis S.P., Stange E.F., Lémann M., Oresland T., Chowers Y., Forbes A., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006, 55(Suppl. 1):i16-35.
4. Caprilli R., Gassull M.A., Escher J.C., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006, 55(Suppl. 1):i36-i58.
5. Schreyer A.G., Gölder S., Seitz J., Herfarth H. New diagnostic avenues in inflammatory bowel diseases. Capsule endoscopy, magnetic resonance imaging and virtual enteroscopy. Dig Dis 2003, 21:129-137.
6. Boudiaf M., Jaff A., Soyer P., Bouhnik Y., Hamzi L., Rymer R. Small bowel diseases: prospective evaluation of multi-detector row helical CT enteroclysis in 107 consecutives patients. Radiology 2004, 203:338-344.
7. Hassan C., Cerro P., Zullo A., Spina C., Morini S. Computed tomography enteroclysis in comparison with ileoscopy in patients with Crohn's disease. Int J Colorectal Dis 2003, 18:121-125.
8. Chiorean M.V., Sandrasegaran K., Saxena R., Maglinte D.D., Nakeeb A., Johnson C.S. Correlation of CT enteroclysis with surgical pathology in Crohn's disease. Am J Gastroenterol 2007, 102:2541-2550.
9. Vogel J., da Luz Moreira A., Baker M., Hammel J., Einstein D., Stocchi L., et al. CT enterography for Crohn's disease: accurate preoperative diagnostic imaging. Dis Colon Rectum 2007, 50:1761-1769.
10. Colombel J.F., Solem C.A., Sandborn W.J., Booya F., Loftus E.V., Harmsen W.S., et al. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut 2006, 55:1561-1567.
11. Malagò R., Manfredi R., Benini L., D'Alpaos G., Mucelli R.P. Assessment of Crohn's disease activity in the small bowel with MR-enteroclysis: clinicoradiological correlations. Abdom Imaging 2008, 33:669-675.
12. Masselli G., Casciani E., Polettini E., Gualdi G. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn's disease. Eur Radiol 2008, 18:438-447.
13. Negaard A., Paulsen V., Sandvik L., Berstad A.E., Borthne A., Try K., et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis. Eur Radiol 2007, 17:2294-2301.
14. Maglinte D.D. Capsule imaging and the role of radiology in the investigation of diseases of the small bowel. Radiology 2005, 236:763-767.
15. Gassull M.A. Review article: the role of nutrition in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2004, 20(Suppl 4):79-83.
16. Van Assche G., Geboes K., Rutgeerts P. Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis 2004, 10:55-60.
17. Louis E., Boverie J., Dewit O., Baert F., De Vos M., D'Haens G., et al. Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study. Acta Gastroenterol Belg 2007, 70:15-19.
18. Lichtenstein G.R., Olson A., Travers S., Diamond R.H., Chen D.M., Pritchard M.L., et al. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease. Am J Gastroenterol 2006, 101:1030-1038.
19. Marrache F., Gornet J.M., Pacault V., Ben Hriz F., Allez M., Nachury M., et al. Effet de l'infliximab au cours de la maladie de Crohn chez les patients ayant une sténose digestive. Gastroenterol Clin Biol 2006, 30:188. [abstract].
20. Colombel J.F., Loftus E.V., Tremaine W.J., Pemberton J.H., Wolff B.G., Young-Fadok T., et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004, 99:878-883.
21. Couckuyt H., Gevers A.M., Coremans G., Hiele M., Rutgeerts P. Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn's strictures: a prospective longterm analysis. Gut 1995, 36:577-580.
22. Hassan C., Zullo A., De Francesco V., Ierardi E., Giustini M., Pitidis A., et al. Systematic review: endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther 2007, 26:1457-1464.
23. Blomberg B., Rolny P., Järnerot G. Endoscopic treatment of anastomotic strictures in Crohn's disease. Endoscopy 1991, 23:195-198.
24. Sabaté J.M., Villarejo J., Bouhnik Y., Allez M., Gornet J.M., Vahedi K., et al. Hydrostatic balloon dilatation of Crohn's strictures. Aliment Pharmacol Ther 2003, 18:409-413.
25. Keuchel M. Double balloon (push-and-pull) enteroscopy: breakthrough in the management of small intestinal strictures in Crohn's disease?. Eur J Gastroenterol Hepatol 2007, 19:523-525.
26. Lavy A. Triamcinolone improves outcome in Crohn's disease strictures. Dis Colon Rectum. 1997, 40:184-186.
27. Ramboer C., Verhamme M., Dhondt E., Huys S., Van Eygen K., Vermeire L. Endoscopic treatment of stenosis in recurrent Crohn's disease with balloon dilation combined with local corticosteroid injection. Gastrointest Endosc 1995, 42:252-255.
28. Biancone L., Cretella M., Tosti C., Palmieri G., Petruzziello C., Geremia A., et al. Local injection of infliximab in the postoperative recurrence of Crohn's disease. Gastrointest Endosc 2006, 63:486-492.
29. Swaminath A., Lichtiger S. Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohn's colitis. Inflamm Bowel Dis 2008, 14:213-216.
30. Matsuhashi N., Nakajima A., Suzuki A., Akanuma M., Yazaki Y., Takazoe M. Nonsurgical strictureplasty for intestinal strictures in Crohn's disease: preliminary report of two cases. Gastrointest Endosc 1997, 45:176-178.
31. Matsuhashi N., Nakajima A., Suzuki A., Yazaki Y., Takazoe M. Longterm outcome of non-surgical strictureplasty using metallic stents for intestinal strictures in Crohn's disease. Gastrointest Endosc 2000, 51:343-345.
32. Bouhnik Y., Bulois P., Vahedi K., Colombel J.F., Lemann M., Getai D. Extractible polyurethane-covered expandable nitinol stent (PCENS) in the treatment of intestinal strictures in Crohn's disease: preliminary report of seven cases. Gastroenterology 2006, 128(Suppl. 2):w4850.
33. Alves A., Panis Y., Bouhnik Y., Pocard M., Vicaut E., Valleur P. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 2007, 50:331-336.
34. Fell J.M. Control of systemic and local inflammation with transforming growth factor beta containing formulas. JPEN J Parenter Enteral Nutr. 2005, 29(Suppl. 4):S126-S128. [discussion S129-33, S184-8].
35. Piton G., Cosnes J., Monnet E., Beaugerie L., Seksik P., Savoye G., et al. Risk factors associated with small bowel adenocarcinoma in Crohn's disease: a case-control study. Am J Gastroenterol 2008, 103:1730-1736.